Surinder K. Chander - Concepedia

Author

Surinder K. Chander

Also Known As

Chander, S.K., Chander, Surinder K., S Chander, S K Chander, S. Chander, S. K. Chander, S.K Chander, S.K. Chander, SK Chander, Surinder Chander

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

University of Bath St Mary's Hospital Imperial College London Charing Cross Hospital St George's Hospital

About

Surinder K. Chander is an author at University of Bath specializing in medicine, pharmacology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	930
2	Biochemistry	9	9	307
3	Natural Sciences	4	4	138
4	Cell Biology	3	3	281
5	Biomolecular Engineering	1	1	60

Surinder K. Chander

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Effects of synthetic vitamin d analogues on breast cancer cell proliferation in vivo and in vitro Kay W. Colston, Surinder K. Chander, A. Mackay, Biochemical Pharmacology Tumor BiologyBreast OncologyOncologyChemoprevention StrategyMedicine	1992	229
EB1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro Kay W. Colston, Alan Mackay, Sharon Y. James, Biochemical Pharmacology Tumor BiologyBreast OncologyMedicineBreast Cancer CellsPharmacology	1992	225
Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents Christopher R. Ireson, Surinder K. Chander, A. Purohit, British Journal of Cancer	2004	120
Clinical and biological significance of HSP89 alpha in human breast cancer A. Jameel, Robert A. Skilton, T Campbell, International Journal of Cancer	1992	118
17β‐hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone‐dependent breast cancer Joanna M. Day, Paul Foster, Helena J. Tutill, International Journal of Cancer	2008	106
Pyrrolidino-4-iodotamoxifen and 4-iodotamoxifen, new analogues of the antiestrogen tamoxifen for the treatment of breast cancer. Surinder K. Chander, R. MCCAGUE, Yunus A. Luqmani, PubMed Medicinal ChemistryBreast OncologyAntiestrogen TamoxifenEstrogen Receptor BindingChemoprevention Strategy	1991	84
Highly Potent First Examples of Dual Aromatase−Steroid Sulfatase Inhibitors based on a Biphenyl Template L. W. Lawrence Woo, Toby Jackson, Aurélien Putey, Journal of Medicinal Chemistry	2010	80
Dual Aromatase−Steroid Sulfatase Inhibitors L. W. Lawrence Woo, Christian Bubert, Oliver B. Sutcliffe, Journal of Medicinal Chemistry	2007	78
First Dual Aromatase-Steroid Sulfatase Inhibitors L. W. Lawrence Woo, Oliver B. Sutcliffe, Christian Bubert, Journal of Medicinal Chemistry	2003	70
Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor Zili An, Xiaoen Wang, N. Willmott, Clinical & Experimental Metastasis	1997	61

Page 1